PL-1
      "Chirality Role in Drug Discovery and Development as Studied by
 Circular Dichrosm"
      Carlo Bertucci
      University of Bologna 
       PL-2
        "Atropisomerism in Drug Design;Effects on 
Neurokinin 1 Antagonists for Depression"
        Jeffrey S. Albert
        AstraZeneca Pharmaceuticals 
      
 PL-3
        "Homochirality, the Signature of Life"
        Meir Lahav
        The Weizmann Institute of Science
      
 PL-4
        "Chirality-the Origin of Biomolecular Asymmetry"
        Uwe J. Meierhenrich
       University of Nice-Sophia Antipolis
      
 PL-5
        "Discovery of the Chiral Clinical Candidate UK-396082:
A Potential Treatment for Thrombosis"
        
        Dafydd Owen
Phizer Global Research and Development
      
 PL-6
        "Synthesis and SAR Studies of Marine Cyclic Peptides and Alkaloids"
        Dawei Ma
        Shanghai Institute of Organic Chemistry
      
 PL-7
        "Antibodies as Binders of Chiral Molecules"
        Juha Rouvinen
        University of Joensuu
      
 PL-8
        "Clinical Relevance of Stereoselective Metabolism and Disposition of 
Proton Pump Inhibitors: Comparison of Lansoprazole to Omeprazole"
        Jae-Gook Shin
Inje University